Dianthus Therapeutics, Inc. /DE/ — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| GARDNER JASON | See Remarks | Sale | 76,711 | $15.16 | $1,162,939 | 268,109 | Dec 20, 2019 |
| DAVIS JOHN C. JR | Chief Medical Officer | Sale | 919 | $15.00 | $13,785 | 8,304 | Dec 20, 2019 |
| GARDNER JASON | See Remarks | Sale | 4,392 | $15.10 | $66,319 | 344,820 | Dec 10, 2019 |
| DAVIS JOHN C. JR | Chief Medical Officer | Sale | 4,614 | $15.00 | $69,210 | 8,304 | Dec 9, 2019 |
| COOKE MICHAEL P. | Chief Scientific Officer | Sale | 3,627 | $12.74 | $46,208 | 244,396 | Dec 2, 2019 |
| COOKE MICHAEL P. | Chief Scientific Officer | Sale | 5,000 | $12.00 | $60,000 | 248,023 | Nov 20, 2019 |
| COOKE MICHAEL P. | Chief Scientific Officer | Sale | 5,000 | $10.67 | $53,350 | 253,023 | Nov 1, 2019 |
| COOKE MICHAEL P. | Chief Scientific Officer | Sale | 5,000 | $10.01 | $50,050 | 258,023 | Oct 1, 2019 |
| COOKE MICHAEL P. | Chief Scientific Officer | Sale | 1,656 | $12.00 | $19,872 | 263,023 | Sep 19, 2019 |
| COOKE MICHAEL P. | Chief Scientific Officer | Sale | 844 | $12.00 | $10,128 | 264,679 | Sep 12, 2019 |
| COOKE MICHAEL P. | Chief Scientific Officer | Sale | 5,000 | $10.11 | $50,550 | 265,523 | Sep 3, 2019 |
| COOKE MICHAEL P. | Chief Scientific Officer | Sale | 2,500 | $13.41 | $33,525 | 270,523 | Aug 1, 2019 |
| COOKE MICHAEL P. | Chief Scientific Officer | Sale | 5,000 | $14.39 | $71,950 | 280,523 | Jul 1, 2019 |
| ISACSON CHRISTINA K. | Chief Business Officer | Sale | 5,415 | $16.07 | $87,019 | 98,116 | Jun 21, 2019 |
| GARDNER JASON | See Remarks | Sale | 12,331 | $15.11 | $186,321 | 349,212 | Jun 20, 2019 |
| COOKE MICHAEL P. | Chief Scientific Officer | Sale | 7,500 | $13.90 | $104,250 | 285,523 | Jun 17, 2019 |
| Atlas Venture Associates X, LLC | — | Other | 726,500 | — | — | 4,117,125 | Mar 20, 2019 |
| Booth Bruce | — | Other | 726,500 | — | — | 4,117,125 | Mar 20, 2019 |
| BONNEY MICHAEL W | — | Gift | 150,000 | — | — | 65,346 | Feb 27, 2019 |
| ATLAS VENTURE ASSOCIATES X, L.P. | — | C | 4,746,876 | — | — | 4,843,625 | Jun 25, 2018 |
| Scadden David | — | Purchase | 6,600 | $15.00 | $99,000 | 228,175 | Jun 25, 2018 |
| Third Rock Ventures GP IV, L.P. | — | C | 7,911,455 | — | — | 8,008,204 | Jun 25, 2018 |
| Daniel Thomas O | — | C | 24,527 | — | — | 101,926 | Jun 25, 2018 |
| RONNEBERG AMY L | — | C | 593,611 | — | — | 593,611 | Jun 25, 2018 |
| COOKE MICHAEL P. | Chief Scientific Officer | C | 4,370 | — | — | 293,023 | Jun 25, 2018 |
| ZDRAVESKI ZORAN | See Remarks | C | 4,643 | — | — | 140,092 | Jun 25, 2018 |
| ISACSON CHRISTINA K. | Chief Business Officer | C | 2,912 | — | — | 103,531 | Jun 25, 2018 |
| Alphabet Inc. | — | C | 3,339,137 | — | — | 3,339,137 | Jun 25, 2018 |
| Booth Bruce | — | C | 4,746,876 | — | — | 4,843,625 | Jun 25, 2018 |
| BONNEY MICHAEL W | — | C | 21,847 | — | — | 215,346 | Jun 25, 2018 |
| Albers Jeffrey W. | — | C | 4,152 | — | — | 4,152 | Jun 25, 2018 |
| BYERS BLAKE | — | C | 3,339,137 | — | — | 3,339,137 | Jun 25, 2018 |
| DAVIS JOHN C. JR | Chief Medical Officer | C | 8,304 | — | — | 8,304 | Jun 25, 2018 |
| GARDNER JASON | See Remarks | Purchase | 400 | $15.00 | $6,000 | 363,212 | Jun 25, 2018 |
| Borisy Alexis | — | C | — | — | — | — | Jun 25, 2018 |